StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance NASDAQ ATHX opened at $0.02 on Friday. The firm has a market cap of $439,087.50, a price-to-earnings ratio of -0.01 and a beta […]